Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.55 – $1.92
41% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.4M | $8.7M | $8.3M | $10.0M | $2.1M | $750.0K | $4.3M | $4.8M |
| Cost of revenue | $77.4M | $85.8M | $0 | $110.5M | $152.4M | $2.4M | $3.5M | $3.4M |
| Gross profit | −$61.0M | −$77.2M | $8.3M | −$100.5M | −$150.3M | −$1.6M | $4.3M | $1.3M |
| Gross margin | -372.8% | -888.1% | 100.0% | -1007.0% | -7193.4% | -218.9% | 100.0% | 28.1% |
| R&D | $57.3M | $65.2M | $61.2M | $81.5M | $116.1M | $96.2M | $54.3M | $57.8M |
| Operating income | −$104.0M | −$135.4M | −$119.5M | −$150.3M | −$197.8M | −$146.2M | −$136.1M | −$100.7M |
| EBITDA | −$37.6M | $476.1M | −$144.8M | $26.2M | −$51.2M | −$11.9M | $37.4M | −$97.3M |
| Net income | −$43.7M | $421.1M | $6.0M | −$60.6M | −$50.4M | −$65.7M | $53.5M | −$112.2M |
| Net margin | -266.7% | 4847.4% | 71.8% | -606.9% | -2409.3% | -8759.6% | 1240.1% | -2355.4% |
| EPS (diluted) | -0.16 | 1.50 | 0.02 | -0.21 | -0.18 | -0.24 | 0.20 | -0.47 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11M | $-0.53 | $-0.53–$-0.53 | 1 |
| 2027 | $20M | $-0.39 | $-0.39–$-0.39 | 1 |
| 2028 | $35M | $-0.22 | $-0.22–$-0.22 | 1 |
Forward consensus · source: Financial Modeling Prep
PURETECH HEALTH PLC ORD
No one on the platform currently holds PTCHF.
No tracked institution reports a position in PTCHF as of their last filing.
No one on the platform has traded PTCHF yet.
| +2.13% |
| $363M |
| — |
| FGHQFFrontage Holdings Corporation | $0.14 | +0.00% | $274M | — |
| HLOSFHealios K.K. | $1.80 | +0.00% | $194M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 25.9× sales vs its 150.7× historical median P/S.
Fair value ≈ $9.88 · price $1.70 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.